Boxer Capital Management’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
CFM
Boxer Capital Management's NAUT Position: Q4 2021 in Review
Boxer Capital Management sold out of Nautilus Biotechnolgy (NAUT) in Q4 2021, closing a stake of 750,000 shares — an estimated $4.6M sold.
Boxer Capital Management first reported a position in NAUT in Q3 2020 and held it in 3 quarters. The position peaked at $7.58M in Q2 2021. 81 funds tracked by Wall St. Rank hold NAUT as of Q4 2021.
- Boxer Capital Management reported no remaining Nautilus Biotechnolgy position as of Q4 2021 after selling out during the quarter.
- Boxer Capital Management sold 750,000 Nautilus Biotechnolgy shares in Q4 2021, an estimated $4.6M.
- Boxer Capital Management first reported a position in Nautilus Biotechnolgy in Q3 2020 and held it in 3 quarters.
- Boxer Capital Management's Nautilus Biotechnolgy position peaked at $7.58M in Q2 2021.
- 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2021.
Based on Boxer Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.